Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
148.18M | 138.61M | 130.78M | 114.88M | 75.84M | Gross Profit |
58.48M | 49.25M | 49.64M | 44.06M | 38.74M | EBIT |
36.50M | 32.51M | 34.45M | 29.86M | 25.52M | EBITDA |
29.61M | 33.94M | 35.68M | 29.73M | 27.11M | Net Income Common Stockholders |
24.03M | 19.62M | 19.62M | 13.60M | 11.07M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
27.80M | 21.03M | 29.86M | 50.06M | 81.06M | Total Assets |
53.48M | 48.86M | 58.61M | 78.52M | 108.81M | Total Debt |
7.85M | 66.39M | 86.24M | 116.52M | 156.22M | Net Debt |
-19.95M | 45.36M | 56.38M | 66.46M | 75.16M | Total Liabilities |
69.99M | 81.78M | 103.17M | 133.50M | 171.29M | Stockholders Equity |
-16.51M | -32.92M | -44.56M | -54.99M | -62.48M |
Cash Flow | Free Cash Flow | |||
25.02M | 19.69M | 19.21M | 15.84M | 11.21M | Operating Cash Flow |
25.24M | 20.00M | 19.84M | 16.48M | 11.77M | Investing Cash Flow |
-225.00K | -313.00K | -584.00K | -636.00K | -551.00K | Financing Cash Flow |
-18.24M | -28.52M | -39.45M | -46.84M | -7.27M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $2.85B | 18.09 | 46.60% | 1.84% | 4.42% | 48.23% | |
66 Neutral | $472.17M | 19.68 | -102.54% | 1.73% | 6.91% | 22.33% | |
65 Neutral | $1.70B | 21.94 | -20.16% | 3.63% | -2.77% | 4.01% | |
62 Neutral | $6.90B | 11.05 | 2.80% | 4.27% | 2.67% | -24.92% | |
56 Neutral | $1.24B | ― | -12.56% | 2.43% | -15.46% | 3.24% | |
52 Neutral | $15.01M | 35.16 | 4.99% | ― | 3.95% | 1180.00% | |
50 Neutral | $374.76M | ― | 4.15% | 9.03% | -6.02% | -136.86% |